Mortality from malaria in France, 2005 to 2014.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
09 2020
Historique:
entrez: 11 9 2020
pubmed: 12 9 2020
medline: 6 1 2021
Statut: ppublish

Résumé

IntroductionMalaria is a notifiable disease in all European Union and European Economic Area countries except Belgium and France, where only autochthonous malaria is notifiable. Although morbidity caused by malaria has been assessed, little is known about mortality incidence.ObjectiveOur aim was to estimate the number of imported malaria-related deaths in hospital in metropolitan France.MethodsWe matched individual deaths reported between 1 January 2005 and 31 December 2014 to the French National Reference Centre for malaria (FNRCm) with malaria-related deaths from two other sources: the French National Registry on medical causes of death and the French national hospital discharge database. A capture-recapture method with log-linear modelling was used. Age, sex and place of death stratification were applied to remove heterogeneity.ResultsThe estimated malaria-related deaths in metropolitan France during the study period were 205 (95% confidence interval (CI): 191-219). The annual mean number of malaria-related deaths was estimated at 21 (95% CI: 19-22). The FNRCm malaria-related deaths surveillance had a 38% sensitivity (95% CI: 32-44). Among 161 in-hospital individual malaria-related deaths reported from three data sources, the sex ratio (male to female) was 2.6. Median age of the patients was 57 years, ranging from 1 to 89 years.ConclusionThe pertinent finding of this report is that malaria-related death records were significantly less complete [corrected] than case records. Therefore, data comparison of imported malaria morbidity and mortality between countries should imperatively be assessed using standard indicators weighted according to the completeness of health surveillance systems.

Identifiants

pubmed: 32914747
doi: 10.2807/1560-7917.ES.2020.25.36.1900579
pmc: PMC7502900
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : ErratumIn

Références

Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
Ann Intern Med. 2004 Oct 5;141(7):547-55
pubmed: 15466772
Med Mal Infect. 2020 Mar;50(2):99-112
pubmed: 31257063
Epidemiol Infect. 2002 Oct;129(2):371-7
pubmed: 12403113
Ann Intern Med. 1990 Aug 15;113(4):326-7
pubmed: 2197915
Lancet Infect Dis. 2017 Jan;17(1):98-107
pubmed: 27777030
Epidemiol Rev. 1995;17(2):243-64
pubmed: 8654510
Med Mal Infect. 2008 Feb;38(2):54-67, 39-53
pubmed: 18646360
J Travel Med. 2005 Mar-Apr;12(2):61-5
pubmed: 15996449
Eur J Epidemiol. 1994 Aug;10(4):399-403
pubmed: 7843343
Travel Med Infect Dis. 2015 Jan-Feb;13(1):48-60
pubmed: 25022610
Eur J Public Health. 2016 Jun;26(3):403-6
pubmed: 27069002
Med Mal Infect. 2008 Feb;38(2):68-117
pubmed: 18646361
Clin Infect Dis. 2020 Jan 2;70(2):280-287
pubmed: 30874798
Epidemiol Infect. 2010 Jul;138(7):1052-8
pubmed: 19919729
BMC Infect Dis. 2013 Mar 05;13:118
pubmed: 23497139
World Health Stat Q. 1988;41(1):32-6
pubmed: 3376487
Emerg Infect Dis. 2007 Jun;13(6):883-8
pubmed: 17553228
Emerg Infect Dis. 2012 Aug;18(8):1346-9
pubmed: 22840888
Lancet. 2014 Sep 13;384(9947):1005-70
pubmed: 25059949
J Chronic Dis. 1974 Feb;27(1):25-36
pubmed: 4815069
Trans R Soc Trop Med Hyg. 1994 May-Jun;88(3):314
pubmed: 7974674
BMJ. 2012 Mar 27;344:e2116
pubmed: 22454091
Clin Infect Dis. 2010 Mar 15;50(6):826-32
pubmed: 20156059
JAMA Netw Open. 2019 Apr 5;2(4):e191691
pubmed: 30951158
J Travel Med. 1996 Jun 1;3(2):96-102
pubmed: 9815432
Clin Infect Dis. 2007 May 1;44(9):e69-72
pubmed: 17407027
PLoS One. 2010 Oct 08;5(10):e13236
pubmed: 20949045

Auteurs

Eric Kendjo (E)

Sorbonne Université, INSERM, Institut Pierre-Louis d'Epidémiologie et de Santé Publique, AP-HP, Laboratoire de Parasitologie, Mycologie, Hôpital Pitié-Salpêtrière, Paris, France.
AP-HP, Centre National de Référence du Paludisme, Paris, France.

Marc Thellier (M)

Sorbonne Université, INSERM, Institut Pierre-Louis d'Epidémiologie et de Santé Publique, AP-HP, Laboratoire de Parasitologie, Mycologie, Hôpital Pitié-Salpêtrière, Paris, France.
AP-HP, Centre National de Référence du Paludisme, Paris, France.

Harold Noël (H)

Santé Publique France, Direction des Maladies Infectieuses, Saint-Maurice, France.

Stéphane Jauréguiberry (S)

AP-HP, Centre National de Référence du Paludisme, Paris, France.
Sorbonne Université, INSERM, Institut Pierre-Louis d'Epidémiologie et de Santé Publique, AP-HP, Service des Maladies Infectieuses, Hôpital Pitié-Salpêtrière, Paris, France.

Alexandra Septfons (A)

Santé Publique France, Direction des Maladies Infectieuses, Saint-Maurice, France.

Oussama Mouri (O)

Sorbonne Université, INSERM, Institut Pierre-Louis d'Epidémiologie et de Santé Publique, AP-HP, Laboratoire de Parasitologie, Mycologie, Hôpital Pitié-Salpêtrière, Paris, France.
AP-HP, Centre National de Référence du Paludisme, Paris, France.

Frédérick Gay (F)

Sorbonne Université, INSERM, Institut Pierre-Louis d'Epidémiologie et de Santé Publique, AP-HP, Laboratoire de Parasitologie, Mycologie, Hôpital Pitié-Salpêtrière, Paris, France.
AP-HP, Centre National de Référence du Paludisme, Paris, France.

Ilhame Tantaoui (I)

Sorbonne Université, INSERM, Institut Pierre-Louis d'Epidémiologie et de Santé Publique, AP-HP, Laboratoire de Parasitologie, Mycologie, Hôpital Pitié-Salpêtrière, Paris, France.
AP-HP, Centre National de Référence du Paludisme, Paris, France.

Eric Caumes (E)

Sorbonne Université, INSERM, Institut Pierre-Louis d'Epidémiologie et de Santé Publique, AP-HP, Service des Maladies Infectieuses, Hôpital Pitié-Salpêtrière, Paris, France.

Sandrine Houzé (S)

Université de Paris, MERIT, IRD, Paris, France.
Centre National de Référence du Paludisme, Hôpital Bichat, AP-HP, Paris, France.

Renaud Piarroux (R)

Sorbonne Université, INSERM, Institut Pierre-Louis d'Epidémiologie et de Santé Publique, AP-HP, Laboratoire de Parasitologie, Mycologie, Hôpital Pitié-Salpêtrière, Paris, France.
AP-HP, Centre National de Référence du Paludisme, Paris, France.
The members of the French imported malaria Study group are acknowledged at the end of this article.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH